drugset / Trial / NCT06688318

Effectivity of Allogenic Umbilical Cord Mesenchymal Stem Cells Conditioned Media for Osteoarthritis of the Knee Joint

NCT06688318 ↗

Phase 1/2 Active not recruiting 11 enrolled National Research and Innovation Agency
NaSingle-groupOpen-labelSupportive care

Summary

Osteoarthritis (OA) is a joint disorder that often occurs and causes disability. This disorder is characterized by an inflammatory reaction in the synovial joints accompanied by a gradual degeneration process in the articular cartilage and sub-chondral bone. Current research has discovered that stem cells produce conditioned media (secretome, extra vesicles, and exosomes) that have tissue regeneration, immunomodulation, anti-inflammatory, and anti-apoptotic capabilities. Research on conditioned media for umbilical cord mesenchymal stem cells is still at the in vivo stage in experimental animals. For this reason, this study aims to conduct clinical experimental research (translational study) in patients with knee joint OA who were given umbilical cord mesenchymal stem cell conditioned media via intra-articular injection.

Timeline

Start
2024-04-03
Primary completion
2024-09-01
Completion
2024-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject umbilical cord mesenchymal stem cell conditioned media Other / unclassified — Other

Indications